Sr. Manager, Clinical Finance BP
Entité: CSL Behring
Catégorie d’emploi: Finance
Famille d’emploi: Finance Business Partner
Type d’emploi: Full Time
Location: Waltham, Massachusetts, United States
Référence de l'employeur: R-293050
Description du poste
The Opportunity:
As the Senior Manager, Clinical Finance Business Partner, you will report to the Director, Clinical Finance and serve as a key Finance Business Partner to Clinical Operations and the broader R&D organization. You will will own the financial management of the clinical study portfolio within assigned TAs, PSTs, assets, and/or studies, with primary responsibility for Clinical Operations external spend, including CROs, clinical vendors, FSP resources, and other study execution costs. You will will provide end-to-end financial oversight across the clinical study lifecycle, from study planning and scenario development through execution, forecasting, governance, and close-out. You will partner closely with Clinical Operations, TA Finance, PSTs, Study Leads, GPLs, CPMs, and other R&D stakeholders to translate clinical and operational assumptions into financial insights and ensure study financials are appropriately reflected in broader asset and portfolio decisions. Beyond core study financial management, upi will provide forward-looking analysis to support clinical development scenario planning, governance, Business Development due diligence, and continuous improvement across Clinical Finance and R&D Finance.
This is a hybrid role, requiring three (3) days of onsite work weekly. #LI-hybrid
The Role:
Clinical Study Financial Management & Business Partnering
- Own the financial management of assigned clinical study portfolios, providing end-to-end financial oversight throughout the study lifecycle.
- Maintain a comprehensive and forward-looking view of study financials, including approved budgets, actuals, commitments, accruals, forecasts, POs, vendor contracts/SOW, and FSP costs.
- Lead PST and Asset level budgeting, forecasting, month-end closing, accrual and prepayment activities, variance analysis, and financial reporting.
- Monitor financial performance against approved budgets and forecasts, proactively identifying and communicating key risks, opportunities, potential gaps, and changes in financial outlook.
- Partner closely with TA Study Leads, GPLs, CPMs, and Clinical Operations to understand study execution and ensure forecasts reflect current assumptions, including timelines, enrollment, site activation, geographic mix, vendor activities, and contractual commitments.
- Collaborate with TA Finance to ensure clinical study financials, assumptions, risks, opportunities, and scenarios are appropriately incorporated into the broader asset and R&D financial outlook.
- Provide clear financial insights and recommendations to support study, portfolio, and business decisions.
Financial Modeling, Scenario Planning & Decision Support
- Develop, enhance, and maintain robust clinical financial models to support study costing, scenario planning, and decision-making, with transparent assumptions, key cost drivers, and sensitivities.
- Lead financial analysis of clinical development scenarios, including alternative study designs, patient populations, enrollment assumptions, timelines, geographic/site strategies, study sequencing, and other key development assumptions.
- Translate clinical and operational scenarios into clear financial implications, sensitivities, risks, opportunities, and investment requirements.
- Provide financial analysis, modeling, and business cases to support PRISM and other R&D governance and investment decisions.
- Partner with Clinical Operations, Clinical Development, TA Finance, PSTs, and other stakeholders to ensure financial scenarios appropriately reflect clinical and operational strategies.
- Clearly communicate complex assumptions and financial implications to Finance and non-Finance stakeholders.
CRO & Vendor Financial Management
- Conduct regular financial reviews with CROs and other clinical study vendors, covering actuals, accruals, commitments, forecasts, change orders, and overall budget status.
- Review and track study work orders and unit-based charges, challenging activity assumptions, unit volumes, rates, and variances against contract, budget, and forecast.
- Assess the financial impact of contract amendments, change orders, and evolving study requirements and ensure these are appropriately reflected in forecasts.
- Partner with R&D contracts & outsourcing team, ensuring alignment among contracts, work orders, POs, invoices, budgets, and forecasts.
Business Development & Due Diligence
- Provide Clinical Finance support for Business Development and due diligence activities, with a focus on clinical development plans and associated costs.
- Develop and evaluate clinical development cost scenarios for potential external opportunities, including study designs, timelines, patient populations, geographic assumptions, and development pathways.
- Review and constructively challenge key assumptions and identify significant cost drivers, sensitivities, risks, and opportunities.
- Partner with Business Development Finance, and other BD project stakeholders to incorporate clinical development costs and scenarios into broader business cases and investment evaluations.
Process Improvement & Broader R&D Finance Contribution
- Proactively identify opportunities to simplify, standardize, automate, and improve Clinical Finance processes, tools, models, and reporting.
- Develop practical and scalable solutions to improve financial transparency, forecast accuracy, efficiency, and decision support.
- Collaborate across R&D Finance to share best practices, strengthen financial capabilities, and improve consistency across teams.
- Contribute to or lead cross-functional initiatives that improve Clinical Finance, R&D Finance, and broader R&D ways of working.
- Maintain a broad R&D perspective and proactively identify opportunities where Clinical Finance expertise can contribute to broader business decisions.
Your Skills & Abilities:
- Bachelor's degree in Finance, Accounting, Business, or a related discipline; MBA or advanced degree preferred.
- 7+ years of relevant Finance, FP&A, R&D Business Operations, or related experience, preferably within the pharmaceutical or biotechnology industry.
- Strong understanding of clinical-stage drug development and clinical trial financial management.
- Strong experience in budgeting, forecasting, accrual management, financial analysis, and financial modeling.
- Ability to translate clinical and operational assumptions into financial scenarios, insights, and recommendations to support business decisions.
- Strong business partnering, communication, and influencing skills, with the ability to collaborate effectively across Clinical Operations, R&D, Finance, and other functions.
- Strong analytical and problem-solving skills, with the ability to work independently, manage multiple priorities, and drive continuous improvement.
CSL Leadership / Behavioral Expectations
- Thinks Beyond – looks beyond current approaches and considers the broader business environment.
- Builds Bridges – proactively collaborates across businesses, functions, and teams.
- Unleashes Outcomes – demonstrates accountability and supports effective decision-making.
- Ignites Agility – embraces and helps drive effective change.
- Inspires the Future – connects day-to-day work with broader organizational direction.
Travel Requirements:
- Domestic and International travel may be required from time to time.
À propos de CSL Behring
CSL Behring est un chef de file mondial en biothérapeutique, mû par sa promesse de sauver des vies. Axée sur la satisfaction des besoins des patients grâce à l'utilisation des technologies les plus récentes, la société découvre, développe et fournit des thérapies innovantes aux personnes souffrant de troubles dans les domaines thérapeutiques de l'immunologie, de l'hématologie, des maladies cardiovasculaires et métaboliques, des maladies respiratoires et de la transplantation. Nous utilisons trois plateformes scientifiques stratégiques : le fractionnement du plasma, la technologie des protéines recombinantes et la thérapie cellulaire et génique, afin de soutenir l'innovation continue et d'affiner constamment les moyens par lesquels les produits peuvent répondre aux besoins médicaux non satisfaits et aider les patients à mener une vie pleine.
CSL Behring exploite l'un des plus grands réseaux de collecte de plasma au monde, CSL Plasma. Notre société mère, CSL, dont le siège social est à Melbourne, en Australie, emploie 32 000 personnes et offre ses thérapies vitales aux populations de plus de 100 pays.
Pour en savoir plus sur CSL, CSL Behring, CSL Seqirus et CSL Vifor, visitez https://www.csl.com/ et sur CSL Plasma, visitez https://www.cslplasma.com/.
Nos avantages sociaux
Pour plus d'informations sur les avantages sociaux de CSL, visitez Comment CSL soutient votre bien-être | CSL.
Votre place est chez CSL
Chez CSL, l'inclusion et l'appartenance sont au cœur de notre mission et de notre identité. Elles alimentent notre innovation au quotidien. En célébrant nos différences et en créant une culture de curiosité et d'empathie, nous sommes en mesure de mieux comprendre nos patients et nos donneurs et d'établir des liens avec eux, de favoriser des relations solides avec nos parties prenantes et de maintenir une main-d'œuvre diversifiée qui fera progresser notre entreprise et notre industrie vers l'avenir.
Pour en savoir plus sur l'inclusion et l'appartenance, visitez https://www.csl.com/careers/inclusion-and-belonging
Employeur offrant l’égalité des chances
CSL est un employeur offrant l'égalité des chances. Si vous êtes une personne handicapée et que vous avez besoin d'un aménagement raisonnable pour une partie du processus de candidature, veuillez visiter https://www.csl.com/accessibility-statement.